Map | A Partnership for Children's Health Search:  | Advanced Search
Home General Information Country Support Board Task Forces Resources Media Center
About the alliance The Vaccine Fund Immunization information
Principles Work plan Background FAQ Glossary Governance Contact us
Printer-friendly format

Quick Reference:

What is GAVI?

Fact sheets

Governance

Board Documents

Guidelines

Press Releases

Immunization Information

Immunization Forum
Latest Issue

GAVI Update

Glossary

Employment

A - B - C - D - E - F - G - H
I - J - K - L - M - N - O - P - Q - R
S - T - U - V - W - X - Y - Z

A
ADC Accelerated Disease Control Initiatives
ADIPs Accelerated Development and Introduction Plans
Annual Progress Report
Antigen
AD syringes Auto-disable syringes
return to top
B
Birth cohort
Bridge Financing
Buffer stock
BOD Burden of disease
return to top
C
Cold chain
Conjugate vaccine
Country Support Process
CVI The Children’s Vaccine Initiative
return to top
D
DTP3 Three doses of Diphtheria, Tetanus and Pertussis
DTaP Diphtheria, Tetanus and Acellular Pertussis vaccine
DTwP Diphtheria, Tetanus, whole cell Pertussis Vaccine
DQA Data Quality Audit
DQS Data Quality Self Assessment
DCVMN Developing Country Vaccine Manufacturers Network
return to top
E
Eligible country
EPI Expanded Program on Immunization
return to top
F
FSP Financial Sustainability Plan
Front-loaded investment
return to top
G
GAVI Global Alliance for Vaccines and Immunization
GAVI Added Value
GAVI Principles
GAVI Strategic Framework
GAVI WP GAVI Work Plan
GIVS Global Immunization Vision and Strategy
return to top
H
hep B or HB Hepatitis B
Hib Haemophilus influenzae type b
HPV Human papillomavirus
return to top
I
ISS Immunization services support
Inactivated vaccine
INS Injection safety
ICC Inter-agency Coordinating Committee
IFF International Finance Facility
IFFIm International Finance Facility for Immunization
IFFIm Co
IC Investment Case
ICF Investment Case Framework
Investment Case Guidelines
return to top
J
JE Japanese Encephalitis
JRF Joint Reporting Form
return to top
L
Live attenuated virus vaccines
LICUS Low Income Countries under Stress
Lyophilized vaccine
return to top
M
MNT Maternal and Neonatal Tetanus
MNTE Maternal and Neonatal Tetanus Elimination
MTEF Medium term expenditure framework
Meningococcal A/C conjugate vaccine
MVP The Meningitis Vaccine Project
MDGs Millennium Development Goals
Monodose
Monovalent vaccine
MYP Multi Year Plan for Immunization
return to top
N
NIDs National Immunization Days
return to top
P
Pentavalent vaccine
Performance based grants
Phase 1
Phase 2
Pneumo ADIP
PRSC Poverty Reduction Strategy Credits
PRSP Poverty reduction strategy paper
Pull mechanisms
Push mechanisms
return to top
R
Hib RAT Hib Rapid Assessment Tool
RED Reach Every District
RVP Rotavirus Vaccine Program
return to top
S
Safety boxes
SWAp Sector Wide Approach
“Shares”
Stockpile
SIA Supplemental Immunization Activities
SWB System-wide barriers
return to top
T
Tetravalent
return to top
U
Under-used Vaccines
Universal Childhood Immunization
Uni-jectTM
User fees
return to top
V
VFTA or TA Vaccine Fund Trust Account at UNICEF (sometimes referred to as UNICEF Trust Account)
VF or TVF The Vaccine Fund
VPD Vaccine Preventable Diseases
VPP Vaccine Provision Project
VVM Vaccine vial monitors
return to top
Y
YF Yellow Fever
return to top

The GAVI glossary is an evolving document, seeking to provide a convenient reference for terms and concepts central to GAVI's work and immunization in general. It is a work in progress and additions and corrections are welcomed. To request a term be added, or if you have any suggestions or feedback, please write to gavi@unicef.org
[ star_int ]   Contact us | Guestbook | Copyrights | Illustrated site